Based on our previous finding of YY1′s OPB domain responsible for its binding of EZH2 and several other oncoproteins, we demonstrated the activities of synthetic YPB and OPB peptides in inhibiting the proliferation of breast cancer cells, but not nontumorigenic cells, and reducing tumor growth in a xenograft mouse model. Here, YY1 is linked to breast carcinoma.